Degree of bilingualism predicts age of diagnosis of Alzheimer's disease in low-education but not in highly educated Hispanics.
Neuropsychologia., Dec;49(14):3826-30 (2011)
Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals.
Alzheimer Dis Assoc Disord., 21(4):292-9 (2007)
Neuromotor abnormalities and risk for psychosis in Alzheimer's disease.
Neurology., Oct;61(7):954-8 (2003)
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
Arch. Neurol., Jan;61(1):59-66 (2004)
Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease.
J. Alzheimers Dis., 30(3):595-603 (2012)
Measuring cognitive change in a cohort of patients with Alzheimer's disease.
Stat Med., 19(11-12):1421-32 (2000)
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Hum. Mol. Genet., Aug;21(15):3500-12 (2012)
Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.
Mol. Cell Proteomics., Oct;10(10):M111.008862 (2011)
Improved Statistical Power of Alzheimer Clinical Trials by Item-Response Theory: Proof of Concept by Application to the Activities of Daily Living Scale.
Alzheimer Dis Assoc Disord., Aug (2012)
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
Proc. Natl. Acad. Sci. U.S.A., Jul;106(29):12145-50 (2009)
Part V. Genetic advances and biological markers for Alzheimer's disease.
Dis Mon., Nov;46(11):731-43 (2000)
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam.
Neurology., May;68(21):1764-71 (2007)
Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks?
Neurology., Mar;46(3):889-91 (1996)